1-20 of 38
Khylia Marshall
Close
Sort by
News

Study Confirms Safety, Efficacy of Mitapivat to Improve Anemia, Decrease Pain Crises in Sickle Cell Disease

Khylia Marshall
Published: 2025
Abstract
March 2025
View News titled, Study Confirms Safety, Efficacy of Mitapivat to Improve Anemia, Decrease Pain Crises in Sickle Cell Disease
News

Initial Results Confirm Safety of Lower-Dose Teclistamab as Maintenance in NDMM

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Initial Results Confirm Safety of Lower-Dose Teclistamab as Maintenance in NDMM
News

Findings Indicate TP53 Alterations Play a Significant Role in Myeloproliferative Neoplasm Disease Progression

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Findings Indicate TP53 Alterations Play a Significant Role in Myeloproliferative Neoplasm Disease Progression
News

Reduced Dose of DOACs May Reduce Bleeding, Health Care Usage in VTE Management

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Reduced Dose of DOACs May Reduce Bleeding, Health Care Usage in VTE Management
News

Rusfertide Shows Durable Control of Hematocrit in Patients With Polycythemia Vera

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Rusfertide Shows Durable Control of Hematocrit in Patients With Polycythemia Vera
News

Blinatumomab Added to Chemotherapy Is New Standard of Care in Newly Diagnosed Childhood SR B-ALL

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Blinatumomab Added to Chemotherapy Is New Standard of Care in Newly Diagnosed Childhood SR B-ALL
News

Pulling Back the Curtain: Dorothea Douglas Lindsay, MD

Khylia Marshall
Published: 2024
Abstract
Mid-November 2024 In this issue, Dorothea Douglas Lindsay, MD, discusses working with children with oncologic and hematologic conditions, her passion for sickle cell disease, and the importance of mentorship.
View News titled, Pulling Back the Curtain: Dorothea Douglas Lindsay, MD
News

End-of-Life Care: A Vital Practice for Every Hematologist

Khylia Marshall
Published: 2024
Abstract
Mid-November 2024
View News titled, End-of-Life Care: A Vital Practice for Every Hematologist
News

Early Aggressive Treatment of High-Risk Smoldering MM Results in High Rates of Sustained uMRD

Khylia Marshall
Published: 2024
Abstract
November 2024
View News titled, Early Aggressive Treatment of High-Risk Smoldering MM Results in High Rates of Sustained uMRD
News

Deep Dive: Matthew Ulrickson, MD

Khylia Marshall
Published: 2024
Abstract
August 2024 In this issue, Matthew Ulrickson, MD, describes his adventures swimming with sharks, recounts how his experience as an NCAA Division I swimmer prepared him for a career in hematology, and explains how swimming is both a way to make connections and disconnect from the stresses of life.
View News titled, Deep Dive: Matthew Ulrickson, MD
News

ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia
News

Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM
News

Mass Spectrometry-Detected MGUS May Have Modifiable Risk Factors

Khylia Marshall
Published: 2024
Abstract
July 2024
View News titled, Mass Spectrometry-Detected MGUS May Have Modifiable Risk Factors
News

Efficacy of PTCy Raises Doubts About the Importance of HLA Matching in AlloHCT

Khylia Marshall
Published: 2024
Abstract
June 2024
View News titled, Efficacy of PTCy Raises Doubts About the Importance of HLA Matching in AlloHCT
News

FLT3-Mutated AML Responds Favorably to Triplet Regimen Including Inhibitor

Khylia Marshall
Published: 2024
Abstract
May 2024
View News titled, FLT3-Mutated AML Responds Favorably to Triplet Regimen Including Inhibitor
News

Genomic Model Predicts Outcomes Better Than Existing Prognostic Methods in Newly Diagnosed Multiple Myeloma

Khylia Marshall
Published: 2024
Abstract
April 2024
View News titled, Genomic Model Predicts Outcomes Better Than Existing Prognostic Methods in Newly Diagnosed Multiple Myeloma
News

Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance

Khylia Marshall
Published: 2024
Abstract
March 2024
View News titled, Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance
News

Time-Limited Ibrutinib, CD19-Directed CAR-T Combo Shows Efficacy for Poor-Risk, R/R Mantle Cell Lymphoma

Khylia Marshall
Published: 2024
Abstract
February 2024
View News titled, Time-Limited Ibrutinib, CD19-Directed CAR-T Combo Shows Efficacy for Poor-Risk, R/R Mantle Cell Lymphoma
News

Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL

Khylia Marshall
Published: 2024
Abstract
February 2024
View News titled, Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL
News

Dosing Recommendations After Elranatamab Interruptions Decrease CRS Events in R/R MM

Khylia Marshall
Published: 2023
Abstract
January 2024
View News titled, Dosing Recommendations After Elranatamab Interruptions Decrease CRS Events in R/R MM